240 related articles for article (PubMed ID: 12715953)
1. Acetylator status, drug metabolism and disease.
Pande JN; Pande A; Singh SP
Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic NATs and cancer predisposition.
Hirvonen A
IARC Sci Publ; 1999; (148):251-70. PubMed ID: 10493262
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
4. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
5. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism].
Furet Y; Bechtel Y; Le Guellec C; Bechtel PR; Autret-Leca E; Paintaud G
Therapie; 2002; 57(5):427-31. PubMed ID: 12611196
[TBL] [Abstract][Full Text] [Related]
6. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
7. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
Hein DW; Zhang X; Doll MA
Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287
[TBL] [Abstract][Full Text] [Related]
8. [N-acetyltransferase genetic polymorphism and its role in the development of neoplastic disease].
Lutz W
Med Pr; 2000; 51(3):277-84. PubMed ID: 11002474
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue.
Bell DA; Badawi AF; Lang NP; Ilett KF; Kadlubar FF; Hirvonen A
Cancer Res; 1995 Nov; 55(22):5226-9. PubMed ID: 7585580
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
[TBL] [Abstract][Full Text] [Related]
11. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver.
Hein DW; Rustan TD; Bucher KD; Martin WJ; Furman EJ
Drug Metab Dispos; 1991; 19(5):933-7. PubMed ID: 1686239
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
13. [Biochemical, molecular genetic and ecogenetic studies of polymorphic arylamine N-acetyltransferase (NAT2) in the brain].
Ogawa M
Fukuoka Igaku Zasshi; 1999 Apr; 90(4):118-31. PubMed ID: 10361374
[TBL] [Abstract][Full Text] [Related]
14. Acetylation.
Weber WW
Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
[TBL] [Abstract][Full Text] [Related]
15. Human acetyltransferase polymorphisms.
Grant DM; Hughes NC; Janezic SA; Goodfellow GH; Chen HJ; Gaedigk A; Yu VL; Grewal R
Mutat Res; 1997 May; 376(1-2):61-70. PubMed ID: 9202739
[TBL] [Abstract][Full Text] [Related]
16. 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop.
Rodrigues-Lima F; Dupret JM
Biochem Biophys Res Commun; 2002 Feb; 291(1):116-23. PubMed ID: 11829470
[TBL] [Abstract][Full Text] [Related]
17. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Hein DW; Doll MA
Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
[TBL] [Abstract][Full Text] [Related]
18. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.
Hein DW
Oncogene; 2006 Mar; 25(11):1649-58. PubMed ID: 16550165
[TBL] [Abstract][Full Text] [Related]
19. [The biological role of prokaryotic and eukaryotic N-acetyltransferase].
Zabost A; Zwolska Z; Augustynowicz-Kopeć E
Pneumonol Alergol Pol; 2013; 81(2):137-44. PubMed ID: 23420430
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of N-acetyltransferases 1 and 2 (NAT1 and NAT2) in cynomolgus and rhesus macaques.
Uno Y; Murayama N; Yamazaki H
Biochem Pharmacol; 2020 Jul; 177():113996. PubMed ID: 32339492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
